Published in J Neurooncol on December 07, 2006
Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer (2008) 3.98
Epidemiology and etiology of meningioma. J Neurooncol (2010) 3.64
The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol (2007) 2.30
Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk. Brain Pathol (2009) 0.97
Survival and low-grade glioma: the emergence of genetic information. Neurosurg Focus (2015) 0.91
Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis. Neuro Oncol (2014) 0.91
A role for the p53 pathway in the pathology of meningiomas with NF2 loss. J Neurooncol (2008) 0.88
Genetic variations in EGF and EGFR and glioblastoma outcome. Neuro Oncol (2010) 0.87
Association of methionine synthase rs1801394 and methionine synthase reductase rs1805087 polymorphisms with meningioma in adults: A meta-analysis. Biomed Rep (2014) 0.80
TP53 codon 72 polymorphism and glioma risk: A meta-analysis. Oncol Lett (2011) 0.79
The vitamin D receptor (VDR) gene polymorphisms in Turkish brain cancer patients. Biomed Res Int (2013) 0.78
Characterization and identification of hidden rare variants in the human genome. BMC Genomics (2015) 0.76
[Hereditary tumor syndromes in neuropathology]. Pathologe (2017) 0.75
Screening and prostate-cancer mortality in a randomized European study. N Engl J Med (2009) 35.94
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Prostate-cancer mortality at 11 years of follow-up. N Engl J Med (2012) 16.91
Cumulative association of five genetic variants with prostate cancer. N Engl J Med (2008) 15.34
External review and validation of the Swedish national inpatient register. BMC Public Health (2011) 11.28
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med (2014) 9.09
Inflammation in prostate carcinogenesis. Nat Rev Cancer (2007) 9.08
Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62
Quality-of-life effects of prostate-specific antigen screening. N Engl J Med (2012) 7.21
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med (2014) 6.89
Calculating measures of biological interaction. Eur J Epidemiol (2005) 6.82
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet (2008) 6.10
Mobile phone use and the risk of acoustic neuroma. Epidemiology (2004) 6.04
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol (2012) 5.71
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst (2007) 4.85
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol (2011) 4.38
Use of mobile phones and risk of brain tumours: update of Danish cohort study. BMJ (2011) 4.08
Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol (2012) 4.07
Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA (2007) 4.03
Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol (2009) 3.92
Long-term mobile phone use and brain tumor risk. Am J Epidemiol (2005) 3.80
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res (2002) 3.70
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Mobile phone use and brain tumors in children and adolescents: a multicenter case-control study. J Natl Cancer Inst (2011) 3.37
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet (2005) 3.18
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet (2008) 3.14
Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003. J Natl Cancer Inst (2009) 2.90
Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83
Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ (2009) 2.79
Cellular telephone use and risk of acoustic neuroma. Am J Epidemiol (2004) 2.78
FTO genotype is associated with phenotypic variability of body mass index. Nature (2012) 2.77
Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study. Lancet (2002) 2.72
Balancing the harms and benefits of early detection of prostate cancer. Cancer (2010) 2.71
Cardiovascular diseases and risk of hip fracture. JAMA (2009) 2.69
Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study. Eur Urol (2011) 2.62
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood (2007) 2.61
Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer. J Clin Oncol (2012) 2.45
Epidemiologic evidence on mobile phones and tumor risk: a review. Epidemiology (2009) 2.35
An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr (2007) 2.34
Cellular telephone use and cancer risk: update of a nationwide Danish cohort. J Natl Cancer Inst (2006) 2.33
Interaction: A word with two meanings creates confusion. Eur J Epidemiol (2005) 2.32
Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol (2009) 2.32
Personality traits and cancer risk and survival based on Finnish and Swedish registry data. Am J Epidemiol (2010) 2.30
The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol (2007) 2.30
Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res (2009) 2.27
Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res (2008) 2.24
Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med (2003) 2.24
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24
Mobile phone use and risk of glioma in adults: case-control study. BMJ (2006) 2.20
LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J (2004) 2.20
Residential radon and lung cancer--detailed results of a collaborative analysis of individual data on 7148 persons with lung cancer and 14,208 persons without lung cancer from 13 epidemiologic studies in Europe. Scand J Work Environ Health (2006) 2.18
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet (2012) 2.18
Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study. Clin Cancer Res (2003) 2.15
The mutational landscape of prostate cancer. Eur Urol (2013) 2.14
Risk of renal cell carcinoma after hysterectomy. Arch Intern Med (2010) 2.12
Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res (2005) 2.11
Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J (2013) 2.10
Reproductive factors associated with nocturia and urinary urgency in women: a population-based study in Finland. Am J Obstet Gynecol (2008) 2.10
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst (2011) 2.09
Diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter. Eur Urol (2007) 2.09
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst (2007) 2.08
State of the art in research into the risk of low dose radiation exposure--findings of the fourth MELODI workshop. J Radiol Prot (2013) 2.06
Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev (2007) 2.05
Long-term mobile phone use and acoustic neuroma risk. Epidemiology (2014) 2.01
Estimation of absolute risk for prostate cancer using genetic markers and family history. Prostate (2009) 1.99
Regular intercourse protects against erectile dysfunction: Tampere Aging Male Urologic Study. Am J Med (2008) 1.96
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96